Mark James Litton, Chief Business Officer at ALDER BIOPHARMACEUTICALS INC (ALDR), sold 19,720 shares at $30.05 ($593K) on 2016-05-31, disclosed to the SEC on 2016-06-01.
Open-market sale of $593k ALDR by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ALDR | SELL | 2017-10-18 | $204K | — | Filing → |
| ALDR | SELL | 2017-01-20 | $35K | — | Filing → |
| ALDR | SELL | 2017-01-09 | $219K | — | Filing → |